SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NexBio, Inc.’s DAS181 (Fludase(R)) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis